Repaglinide-d5
Repaglinide-d5 is deuterium labeled Repaglinide. Repaglinide is an insulin secretagogue for the treatment of type-2 diabetes mellitus[1].
Product Specifications
CAS Number
[1217709-85-7]
Product Name Alternative
AG-EE 623ZW D5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Isotope-Labeled Compounds; Potassium Channel
Type
Isotope-Labeled Compounds
Related Pathways
Membrane Transporter/Ion Channel; Others
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Purity
98.67
Solubility
DMSO : ≥ 50mg/mL
Smiles
O=C(O)C1=CC=C(CC(N[C@H](C2=CC=CC=C2N3CCCCC3)CC(C)C)=O)C=C1OC([2H])([2H])C([2H])([2H])[2H]
Molecular Formula
C27H31D5N2O4
Molecular Weight
457.62
Precautions
H302, H315, H319, H335
References & Citations
[1]Wang LC, et al. Characteristics of repaglinide and its mechanism of action on insulin secretion in patients with newly diagnosed type-2 diabetes mellitus.Medicine (Baltimore) . 2018 Sep;97 (38) :e12476.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
247507-PE 100 µL
IL12B (Interleukin 12B (Natural Killer Cell Stimulatory Factor 2, Cytotoxic Lymphocyte Maturation Factor 2, p40), CLMF, CLMF2, IL-12B, NKSF, NKSF2) (PE)
Ask
View Details 